Medication error prevention has been an important focus for health professionals for many years. While the incidence of errors in oncology and haematology would appear to be no greater than other specialties, the narrow therapeutic index and high toxicity of antineoplastic drugs make the consequences of chemotherapy mistakes potentially catastrophic. A number of authors have suggested strategies for the prevention of errors in cancer chemotherapy.1 4 Despite this, serious errors continue to occur. As oncology pharmacists we pride ourselves on our ability to protect patients from the potential risks associated with medication errors during cancer treatment. However, are we in danger of becoming complacent? It is very easy to say 'It can never happen to me' or 'It won't happen in my institution'.
展开▼
